We are live on ! Find out more
XBIT icon

XBiotech

62 hedge funds and large institutions have $34.8M invested in XBiotech in 2022 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 22 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 7

2% more funds holding

Funds holding: 61 → 62 (+1)

0.59% less ownership

Funds ownership: 13.84% → 13.24% (-0.59%)

37% less capital inflows, than outflows

Capital inflows: $3.15M | Capital outflows: $5.04M

41% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 22

Holders
62
Holders Change
+1
Holders Change %
+1.64%
% of All Funds
0.97%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
13
Reduced
22
Closed
7
Calls
$11​K
Puts
–
Net Calls
+$11​K
Net Calls Change
+$452​K

XBIT Hedge Fund Activity: Q1 2022 in Review

62 of the 6,363 institutional investors tracked by Wall St. Rank reported a position in XBiotech (XBIT) for Q1 2022, worth a combined $34.8M — down 26% from $46.8M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new XBIT positions and 7 closed out — a net gain of 2 holders — while 13 added to existing stakes and 22 trimmed.

The largest buyer was Dimensional Fund Advisors, adding an estimated $520K. The largest seller was State Street, cutting an estimated $1.15M.

  • 62 institutional investors held XBiotech (XBIT) as of Q1 2022, up from 61 in Q4 2021.
  • Funds reported $34.8M of XBiotech stock for Q1 2022, down 26% quarter-over-quarter.
  • 9 funds opened new XBiotech positions in Q1 2022 and 7 closed out, a net change of +2 holders.
  • The largest XBiotech buyer in Q1 2022 was Dimensional Fund Advisors, an estimated $520K added.
  • The largest XBiotech seller in Q1 2022 was State Street, an estimated $1.15M sold.

Based on aggregated 13F filings for Q1 2022.